March 2025 in “Journal of the American Academy of Dermatology” Discount pharmacies offer cheaper options for hair loss medications than traditional or direct-to-consumer pharmacies.
March 2025 in “Journal of Cutaneous and Aesthetic Surgery” In this study, three different hair serums were tested for their impact on Telogen effluvium in adult females, finding all effective in reducing hair shedding, with the cytokine-based serum showing the most significant improvement, reducing hair fall by 54.6% without adverse effects.
January 2025 in “Annals of Dermatology” In this nationwide cross-sectional study, researchers found that COVID-19 vaccination was associated with an increased risk of hair loss disorders, including total alopecia, alopecia areata, and telogen effluvium, while no significant link was observed between COVID-19 infection and these conditions.
November 2024 in “Neliti” This review discusses the difficulty of diagnosing hypothyroidism due to its diverse, nonspecific symptoms that can vary greatly among patients and often mimic other conditions, which may require healthcare providers to be vigilant across various specialties to recognize and diagnose the condition effectively.
September 2024 in “Archives of Dermatological Research” This study found that both red and green LED therapies combined with a microneedling patch significantly improved hair density and diameter in androgenetic alopecia patients over 24 weeks, with no serious side effects and similar efficacy between the two light wavelengths.
September 2024 in “Indian Journal of Skin Allergy” This review article explores the current use and evidence of stem cell therapy in dermatology, detailing its applications, benefits, and limitations across various skin disorders, while also addressing teledermatology's rise during COVID-19 and proposing its ongoing integration into healthcare delivery.
September 2024 in “Cosmoderma” This study highlights that the popular marketing of biotin for hair loss treatment in healthy individuals lacks scientific support, as evidenced by a review of relevant clinical trials.
September 2024 in “Pediatrics in Review” In this case review, researchers describe a 17-year-old transgender male experiencing clitoromegaly, hirsutism, and oligomenorrhea, investigating conditions like PCOS and non-prescription testosterone use for gender affirmation, and highlighting the importance of gender-affirming care to improve mental health outcomes.
June 2024 in “Clinical Endocrinology and Metabolism” This article examines when it is appropriate to prescribe estrogen for women with hormonal imbalances, utilizing decades of clinical practice, expert consultation, and a comprehensive literature review.
April 2024 in “Tạp chí Y học Thảm hoạ và Bỏng” This review discusses various treatment options for androgenetic alopecia, considering factors such as effectiveness, side effects, and cost, but reports no new clinical results.
April 2024 in “Russian Journal of Preventive Medicine” This review discusses how skin changes like acanthosis nigricans and psoriasis can indicate metabolic syndrome components such as insulin resistance and dyslipidemia, suggesting a potential role for early diagnosis and treatment in reducing cardiovascular risks associated with the syndrome.
This study presents a rare instance of Netherton syndrome diagnosed incidentally in siblings of consanguineous parents, initially misdiagnosed as other skin conditions, emphasizing the need for careful evaluation in chronic skin cases to prevent misdiagnosis.
March 2024 in “Frontiers in Endocrinology” In this study, a bidirectional Mendelian randomization analysis found a causal link between alopecia areata and hypothyroidism, indicating that each condition may influence the other, while no similar relationship was observed between androgenetic alopecia and hypothyroidism.
March 2024 in “Translational Journal of the American College of Sports Medicine” This study highlights that feeding and eating disorders, as well as disordered eating behaviors, are more prevalent among athletes compared to the general population, emphasizing the critical role of athletic trainers in early identification and management.
March 2024 in “Clinical, cosmetic and investigational dermatology” This study found that in healthy adult women, a collagen and antioxidant-rich treatment significantly improved skin elasticity, hydration, texture, and reduced wrinkles and hair fall over 56 days compared to a placebo, indicating its efficacy and safety.
February 2024 in “Urology” This study found that among ten identified medications associated with ejaculatory disorders, Paroxetine and Tamsulosin were mainly linked to delayed and retrograde ejaculation, while Finasteride and Sildenafil were most associated with painful ejaculation and ejaculation failure according to reports from FDA-FAERS and Eudra-Vigilance databases.
This study found that androgenetic alopecia in men was significantly associated with dyslipidemia, particularly in more severe cases, suggesting it could be a marker for systemic illness.
January 2024 in “Wiadomości Lekarskie” This review addresses the historical and cultural perceptions of epilepsy and stresses the importance of understanding its diagnosis and management to lessen its psychological and social impacts, especially given the stigma often associated with this condition.
January 2024 in “Wiadomości Lekarskie” The abstract emphasizes that aerospace medicine is crucial for addressing the health challenges faced by pilots and astronauts in aviation and space environments, focusing on physiological responses and the impact of microgravity and isolation.
January 2024 in “Revista da Associação Médica Brasileira” Bald men should protect their scalps from the sun to reduce skin cancer risk.
January 2024 in “Wiadomości Lekarskie” This historical overview commemorates Grzegorz Józef Wojciech Ziembicki, a pioneering surgical leader at Lviv General Hospital, highlighting his contributions to surgical education, innovative procedures, and anesthesia practices during his tenure from 1882 to 1915.
December 2023 in “REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora” This study highlights the critical role of dermatology in diagnosing a wide range of over 3,000 diseases, beyond cosmetic concerns, emphasizing its importance in identifying systemic diseases and addressing conditions with significant psycho-emotional and potentially life-threatening impacts.
December 2023 in “Journal of family medicine and primary care” This study focused on understanding the psychosocial impact of androgenetic alopecia in Saudi Arabia to potentially improve treatment strategies for hair loss by incorporating stress-coping methods and new therapeutic approaches.
November 2023 in “Journal of Pakistan Society of Internal Medicine.” This review discusses the mechanisms, uses, and side effects of conventional synthetic DMARDs, particularly methotrexate, for rheumatoid arthritis, but reports no new clinical findings.
November 2023 in “Dermatology Research and Reports” This study reported that a 1% ivermectin topical cream for rosacea was stable over six months, showing no significant changes in key physical properties or microbial contamination, suggesting it may reduce chronic antibiotic use in rosacea treatment.
No results were reported in this guideline paper, which was authored by the Task Force for Guidelines for Virtual Consultations of the ISHRS to provide suggestions on effectively offering virtual consultations in hair restoration practice.
October 2023 in “The Open Dermatology Journal” Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.
August 2023 in “Clinical Endocrinology and Metabolism” This article provides evidence on when it is appropriate to prescribe hormone therapy for women by reviewing cases from the author's practice and international literature, emphasizing the importance of primary care in managing hormonal imbalances.
July 2023 in “Journal of Ethnopharmacology” In this triple-blind, randomized clinical trial, researchers found that oral Amla syrup significantly increased the anagen-to-telogen hair ratio and satisfaction levels in women with Female Androgenetic Alopecia compared to placebo, suggesting its potential benefit for treating androgenic hair loss.
July 2023 in “Journal of skin and stem cell” In this study conducted at Baqiyatullah Hospital, it was found that interferon beta (IFNβ) treatment in multiple sclerosis patients commonly led to skin complications, with injection site erythema being most frequent, and also increased hair loss severity.